MNT E

12/09/2022

What is CRRT, and how does it help in medical field?

Continuous Renal Replacement Therapy (CRRT) is a type of blood purification therapy used with patients who are experiencing AKI. Unlike regular dialysis, which takes 3-4 hours, CRRT runs 24 hours a day and is increasingly used in intensive care units for patients with acute kidney failure because it is far gentler on the body.

During this therapy, a patient’s blood passes through a special filter that removes fluid and uremic toxins, returning clean blood to the body. The slow and continuous nature of the process, typically performed over a 24-hour period, allows patients with unstable blood pressure and heart rates, which is termed hemodynamically unstable, to better tolerate this process.

There are six medical products required to perform CRRT on a patient:

-1. Blood pumping machine: the machine pumps the blood, controls the rate of blood flow and includes software to safely monitor therapy delivery

-2. Dialysate: a fluid that carries toxins away from the filter

-3. Replacement fluid: a specialized, sterile fluid also used to flush toxins from the body use use too replace electrolytes, other blood elements and volume lost during the filtration process

-4. Filter: machine component that removes fluid and uremic toxins

-5. Anticoagulation method: a type of drug that helps the blood flow through the system, lessening the likelihood that the blood will clot in the filter

-6. Blood warmer: efficiently maintains a patient's blood temperature during blood purification therapy

09/09/2022

31/08/2022

30/08/2022

MRI May Halve Breast-Cancer Mortality Among Women Carrying Variants in Three Genes

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a new comparative modeling analysis.

The predictions by researchers at the University of Washington School of Medicine (Seattle, WA, USA) involve pathogenic variants in ATM, CHEK2 and PALB2 genes – which collectively are as prevalent as the much-reported BRCA1/2 gene mutations. The researchers contend that their findings support MRI screening in some women earlier than existing guidelines propose. To realize a benefit of cancer screening guidelines based on genetic susceptibility, a woman would need to know she carries an implicated gene variant before receiving a disease diagnosis. More often it’s the case that a genetic test panel is administered after someone tests positive for cancer – too late to be of preventive value for the patient but potentially life-saving for blood relatives who could seek genetic testing.

Using established breast-cancer simulation models, the researchers input age-specific risk estimates involving more than 32,000 breast-cancer patients and a similar number of patients who had no cancer. The simulations compared the combined performance of mammography and MRI against mammography alone, and projected that annual MRI conferred significant additional benefit to these populations. The simulations in this study also predicted the volume of false-positive screening results and benign biopsies, per 1,000 women scanned, that would accompany the researchers’ recommendations for annual MRIs starting earlier. Those projections translate to about four false-positive screening results and one to two benign biopsies per woman over a 40-year screening span, according to the researchers. The team hopes their analysis will aid all organizations that issue guidance for medical oncologists and radiologists.

“Screening guidelines have been difficult to develop for these women because there haven’t been clinical trials to inform when to start and how to screen,” said Dr. Kathryn Lowry, an assistant professor of radiology at the University of Washington School of Medicine. “For women with pathogenic variants in these genes, our modeling analysis predicted a lifetime risk of developing breast cancer at 21% to 40%, depending on the variant. We project that starting annual MRI screening at age 30 to 35, with annual mammography starting at age 40, will reduce cancer mortality for these populations of women by more than 50%.”

“We also found that starting mammograms earlier than age 40 did not have a meaningful benefit but increased false-positive screens,” Lowry added.

30/08/2022

USB Powered Multi-Touch Monitor Allows Control of Surgical Sessions from Anywhere in the OR

A medical video recording system combined with a medical-grade multi-touch monitor offers direct network and Wi-Fi connections to PACS with the ability to control surgical sessions from anywhere in the operating room (OR).

MediCapture Inc. (Plymouth Meeting, PA, USA) has announced the availability of the combination of a premium-quality MVR medical video recording system with a new medical-grade, 10-inch, multi-touch monitor, the MTS101. One of the most scalable and highest performance systems in the industry, the MVR TouchPro offers direct network and Wi-Fi connections to PACS with the ability to control surgical sessions from anywhere in the OR, thanks to the bundled MTS101 multi-touch monitor.

In addition to the MTS101, the MVR TouchPro comes with a host of advanced and unique features, including full-patient workflow, with a DICOM Made Easy upgrade option, for easy and fast retrieval of patient information and transfer of studies to PACS, and a 4K Ultra HD upgrade option to record delicate surgeries in stunning detail. Both upgrades can be instantly accessed with an activation code when ready to add on. The MTS101 multi-touch monitor that comes with the MVR TouchPro can also be purchased alone to use with any other MediCapture MVR medical imaging system, and it is available to original equipment manufacturers (OEMs) of endoscopy and other surgical video equipment.

"The MVR TouchPro with the MTS101 is a complete package for hospitals that require advanced medical video recording systems that are easy to set up and simple to use," said Bernd Jotzat, Product Manager. "Surgical teams can position the monitor anywhere in the OR and handle powerful workflow capability with a swipe of the finger, just like a smartphone."

"A versatile plug and play touch screen monitor was a highly expected add-on from our hospital and OEM customers," said Mike Bishop, President and CEO. "With the increasing need to manage and share video content in the surgical market, MediCapture is also working on several storage and peripheral products that will enhance its MVR systems portfolio."

15/05/2022

How to select original or genuine R-600a gas cylinder.
Please Please 🙏 share this in all HVAC group.
https://youtu.be/imGea0LWW84

07/05/2022

Fuad jemaal ciroo

Create promote our college

07/05/2022

MNT E

We Deals In:
1-Refurbrished Ultrasound Machine's
2-Radiology & General Hospital Item's Etc.

07/05/2022

We Deals In:
1-Refurbrished Ultrasound Machine's
2-Radiology & General Hospital Item's Etc.